Mycoplasma Testing Market, By Product Type, By Technology, By Test Type, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

Mycoplasma Testing Market size was valued at US$ 1,452.54 Million in 2024, expanding at a CAGR of 12.01% from 2025 to 2032.

Mycoplasma testing involves detecting and quantifying Mycoplasma contamination in cell cultures, biologics, and pharmaceutical products to ensure product safety and compliance with regulatory standards. The growing demand for biologics, vaccines, and cell-based therapies is driving the adoption of Mycoplasma testing solutions across research and manufacturing laboratories. Opportunities exist in developing rapid, high-sensitivity assays and automated testing platforms that reduce turnaround times and enhance detection accuracy, which is critical for maintaining quality in large-scale biopharmaceutical production. A prominent trend is the integration of molecular and PCR-based techniques with traditional culture methods to improve reliability while minimizing false negatives. However, the complexity of Mycoplasma detection and variability in test sensitivity pose challenges, limiting adoption in small-scale laboratories and in applications requiring ultra-rapid or high-throughput testing.

Mycoplasma Testing Market- Market Dynamics

Rising demand for contamination control in biopharmaceutical and cell therapy production

The growing adoption of biopharmaceuticals, vaccines, and cell-based therapies is significantly driving the demand for Mycoplasma testing solutions, which play a critical role in ensuring the safety, quality, and regulatory compliance of these products. As manufacturers increasingly scale up production of biologics and therapeutic cell lines, there is a pressing need for rapid and reliable Mycoplasma detection methods to prevent contamination that can compromise product efficacy and patient safety. The trend toward high-throughput and automated testing platforms is further increasing demand, as these solutions enable faster results, consistent accuracy, and integration into modern bio manufacturing workflows. Moreover, the continuous growth in global biologics production, particularly in regions such as North America and Europe, is significantly driving the requirement for sensitive and standardized Mycoplasma testing. For instance, recent data from 2024 indicates that over 75 percent of biopharmaceutical manufacturers perform routine Mycoplasma testing across all cell-based production lines. The expanding use of gene and cell therapies is also intensifying the need for robust contamination monitoring to maintain stringent quality standards.

Mycoplasma Testing Market- Segmentation Analysis:

The Global Mycoplasma Testing Market is segmented on the basis of Product Type, Technology, Test Type, Application, and Region.

The market is segmented into three categories based on product type: Mycoplasma detection kits, reagents & assays, and reference standards. These kits offer rapid, standardized, and validated solutions, reducing time and labor in testing workflows. Reagents & Assays rank second, as they are essential for customizing detection protocols, supporting both manual and automated testing platforms, and enabling higher sensitivity and specificity in molecular and culture-based detection methods. Reference Standards follow, providing critical quality controls and calibration materials to ensure assay accuracy, regulatory compliance, and reproducibility across laboratories. Overall, the market prioritization reflects the need for reliable, efficient, and validated testing solutions that safeguard product quality and meet stringent regulatory standards.

The market is categorized into four segments based on technology: PCR-based testing, ELISA, DNA staining, and microbial culture methods. The PCR-based testing segment leads the market, driven by its high sensitivity, rapid turnaround, and broad adoption in quality control and contamination monitoring workflows. ELISA ranks second, valued for its robust antigen-antibody detection capabilities and applicability in high-throughput screening and quality control processes. DNA Staining follows, used primarily in research and specialized laboratory applications to detect mycoplasma contamination visually, though it is less sensitive and labor-intensive compared to molecular methods. Microbial Culture Methods rank last, as they remain the traditional standard for mycoplasma detection but are slower, require specialized expertise, and have lower throughput, limiting their use in modern, time-sensitive production environments. Overall, prioritization reflects accuracy, speed, and integration with automated workflow.

Mycoplasma Testing Market- Geographical Insights

The Mycoplasma Testing Market shows distinct regional dynamics, with North America leading global demand due to its robust biopharmaceutical industry, advanced laboratory infrastructure, and strict regulatory requirements for contamination control, accounting for about 38-40% of the market share. The United States drives this dominance as major therapeutic and vaccine manufacturers routinely implement mycoplasma testing in quality control protocols. Europe holds the second-largest share, supported by harmonized regulations and expanded biotechnology research in countries such as Germany, the UK, and France, which boosts the adoption of rapid detection solutions. The Asia-Pacific region is the fastest-growing market, propelled by expanding pharmaceutical production in China, India, and Japan and increasing investments in automated testing systems. Strategic developments reinforce regional momentum; for example, bioMerieux partnered with AnaBioTec in May 2024 to advance innovative mycoplasma testing methodologies, and global expansion initiatives by major players are increasing accessibility of kits and services.

Mycoplasma Testing Market- Country Insights

At the country level, the United States is the foremost market for mycoplasma testing, driven by its substantial biopharmaceutical industry, stringent regulatory contamination standards, and extensive R&D activity, which collectively lead to high adoption of advanced testing solutions. North America overall accounted for nearly half of the global market in 2024, with the U.S. as the primary contributor. In Europe, countries such as Germany, the United Kingdom, and France are significant contributors, supported by strong research infrastructure and widespread contamination control initiatives in biologics manufacturing. The Asia-Pacific region, led by China, Japan, and India, is expanding rapidly as pharmaceutical production increases and investment in quality control rises, with China's market projected to grow strongly due to robust domestic biotech activity. Strategic collaborations, such as bioMerieux's 2024 partnership with AnaBioTec to enhance mycoplasma detection methods, further advance country-level capabilities and innovation.

Mycoplasma Testing Market- Competitive Landscape:

The competitive landscape of the Mycoplasma Testing Market is shaped by a mix of established life science firms and specialized diagnostics providers focused on contamination detection solutions. Key players such as Merck KGaA, bioMerieux SA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., and Charles River Laboratories International Inc. compete on the basis of test accuracy, speed, automation compatibility, and global distribution networks. Companies are investing in assay development, automation integration, and expanded service offerings to strengthen market positions. Strategic transactions are actively reshaping competition; for instance, bioMerieux's partnership with AnaBioTec in 2024 aims to co-develop enhanced mycoplasma detection technologies, while Thermo Fisher Scientific's acquisition of Qiagen's Cell Culture and Molecular Diagnostics Business (completed in 2023) expanded its infectious disease and contamination testing portfolio, including mycoplasma solutions. Ongoing collaborations with contract research organizations and genomic service providers further extend the reach of testing platforms, supporting broad adoption in biopharmaceutical manufacturing and research environments. Overall, competitive dynamics prioritize innovation, regulatory compliance, and comprehensive testing solutions.

Recent Developments:

In September 2025, Fuse Diagnostics launched its Flip Mycoplasma rapid mycoplasma contamination test across major European countries through a distribution agreement with CliniSciences, enabling ultra-rapid, simple cell culture quality screening without complex equipment.

Agathos Biologics stated in April 2023 that it would provide life science researchers with analytical testing services. Agathos only uses QIAGEN-developed QIAcuity equipment and assays. Additionally, Agathos and QIAGEN have partnered to test and validate mycoplasma and recombinant adeno-associated viral vector (rAAV) assays.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MYCOPLASMA TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Agilent Technologies
ATCC
Becton, Dickinson and Company
Bio-Rad Laboratories
Charles River Laboratories
Creative Diagnostics
Eurofins Scientific
Fujifilm Irvine Scientific
Hologic
InvivoGen
Lonza Group
Merck KGaA
Meridian Bioscience
Minerva Biolabs
PromoCell
QIAGEN
Roche Diagnostics
Sigma-Aldrich
Takara Bio
Thermo Fisher Scientific
Others

GLOBAL MYCOPLASMA TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Mycoplasma Detection Kits
Reagents & Assays
Reference Standards

GLOBAL MYCOPLASMA TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

PCR-Based Testing
ELISA
DNA Staining
Microbial Culture Methods

GLOBAL MYCOPLASMA TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

Qualitative Testing
Quantitative Testing

GLOBAL MYCOPLASMA TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cell Line Testing
Vaccine Production Testing
Biopharmaceutical Manufacturing
Clinical Diagnostics

GLOBAL MYCOPLASMA TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5963

1. Mycoplasma Testing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Mycoplasma Testing Market Snippet by Product Type
- 2.1.2. Mycoplasma Testing Market Snippet by Technology
- 2.1.3. Mycoplasma Testing Market Snippet by Test Type
- 2.1.4. Mycoplasma Testing Market Snippet by Application
- 2.1.5. Mycoplasma Testing Market Snippet by Country
- 2.1.6. Mycoplasma Testing Market Snippet by Region
2.2. Competitive Insights

3. Mycoplasma Testing Key Market Trends

3.1. Mycoplasma Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Mycoplasma Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Mycoplasma Testing Market Opportunities
3.4. Mycoplasma Testing Market Future Trends

4. Mycoplasma Testing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Mycoplasma Testing Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Mycoplasma Testing Market Landscape

6.1. Mycoplasma Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Mycoplasma Testing Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Mycoplasma Detection Kits
- 7.1.3. Reagents & Assays
- 7.1.4. Reference Standards

8. Mycoplasma Testing Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 8.1.2. PCR-Based Testing
- 8.1.3. ELISA
- 8.1.4. DNA Staining
- 8.1.5. Microbial Culture Methods

9. Mycoplasma Testing Market - By Test Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
- 9.1.2. Qualitative Testing
- 9.1.3. Quantitative Testing

10. Mycoplasma Testing Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 10.1.2. Cell Line Testing
- 10.1.3. Vaccine Production Testing
- 10.1.4. Biopharmaceutical Manufacturing
- 10.1.5. Clinical Diagnostics

11. Mycoplasma Testing Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Mycoplasma Testing Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Mycoplasma Testing Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Mycoplasma Testing Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Mycoplasma Testing Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Mycoplasma Testing Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Mycoplasma Testing Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Agilent Technologies
- 12.2.2. ATCC
- 12.2.3. Becton, Dickinson and Company
- 12.2.4. Bio-Rad Laboratories
- 12.2.5. Charles River Laboratories
- 12.2.6. Creative Diagnostics
- 12.2.7. Eurofins Scientific
- 12.2.8. Fujifilm Irvine Scientific
- 12.2.9. Hologic
- 12.2.10. InvivoGen
- 12.2.11. Lonza Group
- 12.2.12. Merck KGaA
- 12.2.13. Meridian Bioscience
- 12.2.14. Minerva Biolabs
- 12.2.15. PromoCell
- 12.2.16. QIAGEN
- 12.2.17. Roche Diagnostics
- 12.2.18. Sigma-Aldrich
- 12.2.19. Takara Bio
- 12.2.20. Thermo Fisher Scientific
- 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us